Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity
NCT07001904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-06-03
Summary
This study aimed to evaluate serum IL-6 levels in plaque psoriasis patients and investigate their correlation with disease severity.
Conditions
- Interleukin-6
- Plaque Psoriasis
- Disease Severity
Interventions
- OTHER
-
Enzyme-linked immunosorbent assay (ELISA)
The enzyme-linked immunosorbent assay (ELISA) was utilized in order to determine the levels of IL-6 in the serum
Sponsors & Collaborators
-
Tanta University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- Egypt
Study Locations
More Related Trials
-
BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis
NCT02209753 ·Status: COMPLETED ·Phase: PHASE2
-
Excimer Light in Psoriasis
NCT05283876 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
NCT01687582 ·Status: COMPLETED ·Phase: NA
-
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
NCT00617994 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
NCT02274792 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis
NCT04344574 ·Status: UNKNOWN
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
NCT07290569 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Glucose Trnsporter and PEDF in Psoriasis
NCT04242082 ·Status: UNKNOWN
-
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
NCT05279638 ·Status: UNKNOWN
-
Body PSOriasis: Long-term Relapse CONTROL
NCT03402828 ·Status: COMPLETED
-
Efficacy of Pulsed High Intensity Laser Therapy in Psoriatic Hand Arthritis
NCT06665282 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study
NCT06918743 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis
NCT05858047 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
NCT07233291 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT06912165 ·Status: RECRUITING ·Phase: PHASE2
-
Incretin Effect in Patients With Psoriasis and Controls
NCT06064084 ·Status: COMPLETED
-
The Effect of Psoriatic Arthritis on Female Sexual Dysfunction
NCT06370221 ·Status: NOT_YET_RECRUITING
-
Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients
NCT06712238 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
NCT00782613 ·Status: TERMINATED ·Phase: PHASE2
-
Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism
NCT03629639 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Alga Dunaliella Bardawil on Psoriasis
NCT01628081 ·Status: UNKNOWN ·Phase: PHASE3